Concomitant Use of AD Meds Tied to Faster Decline in Trials Concomitant Use of AD Meds Tied to Faster Decline in Trials

The use of cholinesterase inhibitors or memantine must be accounted for in the design and analysis of Alzheimer ' s disease trial data to prevent erroneous conclusions, researchers say.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news